Lobenzarit disodium inhibits the constitutive NO–cGMP metabolic pathways. Possible involvement as an immunomodulatory drug
Padrón, J., Rojas, A., Glaría, L., Caveda, L., Delgado, R., Torres, M., Martínez, O., López, E., Beltrán, A., Palacios, M.Volume:
4
Year:
1995
Language:
english
Journal:
Mediators of Inflammation
DOI:
10.1155/s0962935195000597
File:
PDF, 1.75 MB
english, 1995